Vox Sanguinis

Cover image for Vol. 112 Issue 2

Edited By: Dana V. Devine

Impact Factor: 2.656

ISI Journal Citation Reports © Ranking: 2015: 36/70 (Hematology)

Online ISSN: 1423-0410

Associated Title(s): ISBT Science Series

Author Guidelines

Submission of Manuscripts

All manuscripts should be submitted online at http://mc.manuscriptcentral.com/vox. Please submit all elements of the text in one file only. To submit you will require a user ID and password, which can be obtained on first use of the submission web site. Full instructions are provided. All file types are supported but to help Editors and reviewers view the submission the following types are recommended: text in Microsoft Word or generic rich text format (RTF), figures in Word, TIFF or JPEG format. Please consult the Wiley-Blackwell's electronic artwork guidelines at http://authorservices.wiley.com/bauthor/illustration.asp. Macintosh users are advised to add the correct three-letter filename suffix. It is strongly recommended that, where possible, you combine all parts of your submission into a single document. Full help and support are provided by e-mail (support@scholarone.com) or telephone (+ 1 434-817-2040 ext. 167).

If you cannot submit online please contact the editor:

Dana V. Devine,
Vice-President, Medical, Scientific and Research Affairs
Canadian Blood Services Centre for Blood Research
2350 Health Sciences Mall
Vancouver, BC V6T 1Z3
Tel: 604-822-7270 or 613-739-2231;
Fax: 604-822-7135 or 613-739-2151
Email: dana.devine@blood.ca

Only original papers written in English will be considered for publication. The author who submits a paper for publication is responsible that all other authors agree to its submission, and this should be acknowledged in the covering letter provided during the submission.

All manuscripts are subject to editorial review. No page charges are levied. Manuscripts are received with the explicit understanding that they have not previously been published elsewhere nor are they under simultaneous consideration by any other publisher. Manuscripts must comply with the COPE guidelines (see below).


If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions: http://exchanges.wiley.com/authors/faqs---copyright-_301.html

For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://exchanges.wiley.com/authors/faqs---copyright-_301.html and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by certain funders [e.g. The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF)] you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with your Funder requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://exchanges.wiley.com/authors/faqs---copyright-_301.html and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.


OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley InterScience, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://olabout.wiley.com/WileyCDA/Section/id-406241.html.

Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://authorservices.wiley.com/bauthor/onlineopen_order.asp. Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

Rapid Communications
Manuscripts intended for Rapid Communication must present new findings of sufficient importance to justify their accelerated acceptance. They should follow the general arrangement of research papers with the exception that no abstract or introduction are required. The first paragraph should include the reason for the study and the main findings. They should not exceed 8 double-spaced manuscript pages in length, including figures, tables and references. Proofs are checked by the Editor and not sent to the author. Review will be rapid, and once accepted, the paper will be included in the next available issue.

Original Articles
Original Articles should not exceed 5000 words (including tables, figures, and references)

Short reports, Case reports
They may include up to 1100 words of text, two figures or tables and up to 12 references. A summary of up to 100 words should be followed by continuous text, subdivided if appropriate.

Short reports: Short reports describing completed work on significant novel developments into scientific or clinical aspects of transfusion medicine may be published. Short reports could include important preliminary observations, short methods papers, therapeutic advances, and any significant scientific or clinical observations which are best published in this format. Publication of initial results which will lead to more substantial papers will generally be discouraged.

Case reports: The submission of Case Reports is not encouraged, but they will be considered if the report includes novel scientific material or is of extraordinary clinical interest. Case reports should include a brief description of the case and a comment section discussing the salient features in the context of the World literature.

Letters to the Editor
Letters to the Editor are welcome but should contain no more than 450 words and a maximum of five references.

Presentation of Manuscripts
Papers should be structured as follows: (a) Title Page, (b) Structured abstract, (c) Text, (d) References, (e) Figure and Table Legends, (f) Figures and Tables.

Title page: The first page of each paper should indicate the title, the authors' full names, and the institute where the work was conducted. A short title for use as running head is also required. Give details of sources of research support (where applicable).

Full address: The exact postal address of the author to whom correspondence should be sent, complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as your e-mail address.

Abstract: Each paper needs an abstract of up to 250 words which should be organised as follows:
Background and Objectives: What is the purpose of the study?
Materials and Methods: How was the study done?
Results: Most important findings?
Conclusion: Most important conclusion?

The abstract should include only text. Avoid the use of abbreviations and citations. Supply three to six keywords.

Text: All manuscripts must have an appropriate introduction, a single materials and methods section (with the methodology of all experiments), results and discussion. English spellings should be used. Authors must express measurements in SI Units. Except for units of measurement abbreviations should be spelled out on first use and should be standard. Drug names should be generic, although authors may add brand names in parentheses if they wish.

Electronic Artwork: We would like to receive your artwork in electronic form. Please save vector graphics (e.g. line artwork) in Encapsulated Postscript format (EPS) and bitmap files (e.g. half-tones) in Tagged Image File Format (TIFF). Ideally, vector graphics that have been saved in metafile (.WMF) or pict (.PCT) format should be embedded within the body of the text file. Avoid using tints if possible; if they are essential to the understanding of the figure, try to make them coarse. Always enclose a hard copy of digitally supplied figures. Detailed information on digital illustration standards is available on the Wiley-Blackwell's homepage at http://authorservices.wiley.com/bauthor/illustration.asp.

Colour Figures: It is the policy of Vox Sanguinis for authors to pay the full cost for the reproduction of their colour artwork. Therefore, please note that if there is colour artwork in your manuscript when it is accepted for publication, Wiley-Blackwell requires you to complete and return a colour work agreement before your paper can be published. This form can be downloaded as a PDF here. If you are unable to download the form please contact the production editor at: vox@wiley.com and they will be able to email or fax a form to you.

Once completed, please return the form to the production editor at the address below:

Customer Services (OPI)
John Wiley & Sons Ltd, European Distribution Centre
New Era Estate
Oldlands Way
Bognor Regis
West Sussex PO22

Any article received by Wiley-Blackwell with colour work will not be published until the form has been returned.

Tables: These should be numbered an provided with the manuscript. Each table requires a title; short legend may also be provided if necessary. Please identify footnotes (which should be kept to a minimum and written in bold print) by superscripts, a, b, c etc.  Do not use graphics software to create tables.

References: In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetise; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. List all authors when three or less; when four or more, list the first three and add ', et al.' Journal names must be italicised, and abbreviated according to the Index Medicus system. (Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997;336:309-315.)

(a) Papers published in periodicals:
Ranasinghe E, Harrison JF: Bruising following blood donation, its management and the response and subsequent return rates of affected donors. Trans Med 2000; 10:113-116

(b) Monographs:
Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine, ed 10. Oxford, Blackwell Science, 1997

(c) Edited books:
Luzzatto L, Karadimitris A: The molecular basis of anaemia; in Provan D, Gribben J (ed): Molecular Haematology. Oxford, Blackwell Science, 2000

Reference management
We recommend the use of a tool such as Reference Manager for reference management and formatting.

Reference Manager reference styles can be searched for here:

Supporting Information
Supporting Information can be a useful way for an author to include important but ancillary information with the online version of an article. Examples of Supporting Information include additional tables, data sets, figures, movie files, audio clips, 3D structures, and other related nonessential multimedia files. Supporting Information should be cited within the article text, and a descriptive legend should be included. It is published as supplied by the author, and a proof is not made available prior to publication; for these reasons, authors should provide any Supporting Information in the desired final format. For further information on recommended file types and requirements for submission, please visit: http://authorservices.wiley.com/bauthor/suppinfo.asp

NEW: CrossCheck Plagiarism Software
We would like to inform our authors that we now detect plagiarism more easily through the use of CrossCheck plagiarism software. The journal to which you are submitting your manuscript employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

Ethical Policy
Please read the Ethical Policies of Vox Sanguinis.

All authors must fulfil the following three criteria:

• Substantial contributions to research design, or the acquisition, analysis or interpretation of data,
• Drafting the paper or revising it critically, and
• Approval of the submitted and final versions.

Role of professional medical writers in peer-reviewed publications
Please ensure that you follow the guidelines by the European Medical Writers Association on the role of medical writers. The guidelines emphasise the importance of respecting widely recognised authorship criteria, and in particular of ensuring that all people listed as named authors have full control of the content of papers. The role of professional medical writers must be transparent. Please name any professional medical writer among the list of contributors to any article for Vox Sanguinis (not only original research papers), and specify in the acknowledgements and statement of competing interests for the article who paid the writer. Writers and authors must have access to relevant data while writing papers.

Disclosure and competing interests statement
Authors are required to disclose financial interests in any company or institution that might benefit from their publication. A competing interest exists when a primary interest (such as patients’ welfare or the validity of research) might be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors of a Vox Sanguinis article when they have a financial interest that may influence their interpretation of their results or those of others. Financial interests are the easiest to define and they have the greatest potential to influence the objectivity, integrity or perceived value of a publication. They may include any or all, but are not limited to, the following:

• Personal financial interests: Stocks or shares in companies that may gain or lose financially through publication; consultant fees or fees from speakers bureaus other forms of remuneration from organisations that may gain or lose financially; patents or patent applications whose value may be affected by publication.
Funding: Research support from organisations that might gain or lose financially through publication of the paper.
• Employment: Recent, present or anticipated employment of you or a family member by any organization that may gain or lose financially through publication of the paper. Any such competing interest that authors may have should be declared. The aim of the statement is not to eradicate competing interests, as they are almost inevitable. Papers will not be rejected because there is a competing interest, but a declaration on whether or not there are competing interests will be added to the paper.
• Patent rights
• Consultancy work.

All authors must disclose competing interests, or state “none” via the Journal's ScholarOne Manuscripts website.

All sources of funding must be disclosed in the Acknowledgments section of the paper. List governmental, industrial, charitable, philanthropic and/or personal sources of funding used for the studies described in the manuscript. Attribution of these funding sources is preferred. Examples:

• This work was supported by a grant from the National Institutes of Health, USA (DKxxxx to AB).
• This work was supported by the Crohn's and Colitis Foundation of Canada (grant to AB and CD).
• This work was supported by a grant from Big Pharma Inc. (to AB) and equipment was donated by Small Pharma Inc. EF received a graduate studentship award from the University of xxxxx.

For papers where there are no competing interests, all authors must include the statement ‘Competing interests: the authors have no competing interests.’

We will also ask reviewers to provide a statement of competing interests.

Manuscript Acceptance
After an article has been accepted for publication, the final version should be provided via http://mc.manuscriptcentral.com/vox. Files should be formatted double-spaced with no hyphenation and automatic word-wrap (no hard returns within paragraphs). Please type your text consistently, e.g. take care to distinguish between '1' (one) and 'l' (lower-case L), and '0' (zero) and 'O' (capital o), etc.

Accepted manuscripts will be published from the electronic version. This reduces typesetting errors and speeds up publication. Authors must ensure that all sections of their paper, including tables and figure captions (but not actual figures), are presented in a single file, updated to incorporate all revisions, and that the file matches the final hard copy. In the full-text online edition of the journal, figure legends may be truncated in the abbreviated links to the full-screen version. Therefore, the first 100 characters of any legend should inform the reader of key aspects of the figure.

Manuscript format: Please note that it is imperative the manuscript is uploaded to ScholarOne Manuscripts as a Microsoft Word or RTF file, and not as a PDF file, and that figures are uploaded in Word, TIFF or JPEG format. PDF files cannot be used for copyediting and typesetting; if the final version of your manuscript is supplied as a PDF file, this will delay the production process.

Materials copied from other sources must be accompanied by a written statement from both author and publisher giving permission to the Vox Sanguinis for reproduction. Obtain permission in writing from at least one author of papers still in press, of unpublished data and of personal communications. It is the author's responsibility to ensure that permissions are obtained.

Proofs and Reprints

All manuscripts will be carefully revised by the copy editor. When proofs are ready for checking, the corresponding author will receive an email alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Excessive changes made by the author in the proofs, excluding typesetting errors, will be charged separately.

Free access to the final PDF offprint or your article will be available via author services only. Please therefore sign up for author services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers. Paper offprints can be ordered at the prices quoted on the order form, which accompanies the proofs, provided that the order is returned to the address indicated on the form. 

Diary of Events

We will be pleased to publish details of upcoming Transfusion Medicine events. Please write to the Editor-in-Chief giving dates, name of congress/meeting, venue and secretariat address.

Author Material Archive Policy
Please note that unless specifically requested, Wiley-Blackwell will dispose of all hardcopy or electronic material submitted 2 months after publication. If you require the return of any material submitted, please inform the editorial office or production editor as soon as possible if you have not yet done so.

Paper Policy
The Publisher's policy is to use permanent paper from mills that operate a sustainable forestry policy. Paper has been manufactured from pulp that is processed using acid-free and elementary chlorine-free practices. Furthermore, the Publisher ensures that the text paper and cover board used has met acceptable environmental accreditation standards.

Early View
Vox Sanguinis is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found online at http://www.doi.org/faq.html

Author Services
NEW: Online production tracking is now available for your article through Wiley-Blackwell’s Author Services.
Author Services enables authors to track their article – once it has been accepted – through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

Kudos: New Author Benefit to Increase Readership and Impact
Kudos is a web-based service that helps authors explain, enrich, and share their published work for greater readership and impact. It also provides direct access to a publication dashboard so authors can measure the effect of their actions across a wide range of metrics.

Wiley’s partnership with Kudos makes the service free for all authors publishing in Medical Education and The Clinical Teacher. However, those who have registered with Wiley Author Services and opted into the mailing list will receive the most streamlined experience. The notification emails sent to those who are registered with Wiley Author Services contain a direct link to claim their article in Kudos. Authors who are unregistered or published prior to 2014 can claim authorship in Kudos by searching for articles by DOI, article title, or author name.

Once authors have claimed their articles, they are led through the following steps:
- Explain articles by adding lay summaries and highlighting what makes the work important.
- Enrich articles by adding links to related resources that put the research into context.
- Share via email and social media, while Kudos links across search engines and subject indexes
- Access the dashboard area to view usage, citations, and altmetrics for the publications

Benefits for authors:
- Discoverability and Impact – Increases the likelihood of their articles being found, read, and cited.
- Publication Metrics – Provides direct access to usage, citations, and altmetrics for their articles.
- Networking – Encourages interactions that build relationships and visibility within their communities

Please also see this introductory video and blog post on Wiley Exchanges for more information.

The Publisher, the International Society of Blood Transfusion and the Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher, the International Society of Blood Transfusion  and the Editors; neither does the publication of advertisements constitute any endorsement by the Publisher, the International Society of Blood Transfusion and the Editors of the products advertised.